Quantcast

Health Care Sector Update for 07/20/2017: SBPH,GILD,SRPT,CFRX


Shutterstock photo

Top Health Care Stocks

JNJ +1.29%

PFE -0.19%

ABT +2.99%

MRK +0.79%

AMGN +0.60%

Health care stocks were on top of Thursday's leaderboard, with the NYSE Health Care Index climbing almost 0.9% while shares of health care companies in the S&P 500 were up more than 0.8% as a group.

In company news, Spring Bank Pharmaceuticals ( SBPH ) jumped out to a nearly 13% gain on Thursday, topping out at $16.00 a share after analysts at Cantor Fitzgerald began covering the early-stage biotech company with an Overweight investment recommendation and a $29 price target.

The new rating follows the company's earlier this month announcing a collaboration pact with rival biotech Gilead Sciences ( GILD ) for a second clinical trial of a combination of Spring Bank's SB9200 immunomodulator and Gilead's Vemidy hepatitis B drug treatment.

In other sector news,

(+) SRPT, (+26.2%) Non-GAAP net loss of $0.46 per share is $0.32 per share smaller than Street view. Also reports $35.01 mln in revenue, topping the $22.52 mln consensus. Raises FY17 revenue outlook by $30 mln to a range of $125 mln to $130 mln, exceeding the $105.13 mln consensus call.

(-) CFRX, (-10.3%) Prices $40 mln public offering of 32 mln shares at $1.25 apiece. Also issues warrants to buy up to 16 mln more shares at $1.55 apiece.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.





This article appears in: Investing , US Markets
Referenced Symbols: SBPH , GILD , SRPT , CFRX




More from MT Newswires

Subscribe






MT Newswires
Contributor:

MT Newswires

Market News, Commodities












Research Brokers before you trade

Want to trade FX?